Seroepidemiological Study of Novel Coronavirus Disease (COVID-19) in Tehran, Iran

  1. Zeinab Tabanejad
  2. Nursing Care Research Center, Iran University of Medical Sciences, Tehran, IR. Iran.
  3. Sorena Darvish
  4. Department of Medical Laboratory Sciences, Faculty of Medicine, Babol University of Medical Sciences, Babol, IR. Iran.
  5. Zeinab Borjian Boroujeni
  6. Department of Medical Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, IR. Iran.
  7. Seyed Saeed Asadi
  8. Department of Medical Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, IR. Iran.
  9. Morteza Mesri
  10. Nursing Care Research Center, Iran University of Medical Sciences, Tehran, IR. Iran.
  11. Omid Raiesi
  12. Department of Parasitology, School of Allied Medical Sciences. Ilam University of Medical Sciences, Ilam, Iran.
  13. Muhammad Ebrahim Getso
  14. Department of Medical Microbiology and Parasitology, Faculty of Clinical Sciences, College of Health Sciences, Bayero University, PMB 3011, Kano-Nigeria
  15. Mahdi Zareei
  16. Department of Medical Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, IR. Iran.

Reviewed by

Read the full article See related articles

Listed in

Log in to save this article

Abstract

No abstract available

Article activity feed

  1. Version published to 10.52547/iem.7.2.121
  2. ScreenIT

    SciScore for 10.1101/2021.01.18.20248911: (What is this?)

    Please note, not all rigor criteria are appropriate for all manuscripts.

    Table 1: Rigor

    Institutional Review Board StatementConsent: With their written consent, we included 1375 COVID-19-suspected patients according to the Helsinki Declaration.
    Randomizationnot detected.
    Blindingnot detected.
    Power Analysisnot detected.
    Sex as a biological variablenot detected.

    Table 2: Resources

    Antibodies
    SentencesResources
    We examined for anti-SARS-CoV-2 IgG and IgM antibodies in serum samples from 1375 participants using ELISA kits (IDEAL TASHKHIS Co, IR. Iran).
    anti-SARS-CoV-2 IgG
    suggested: None
    IgM
    suggested: None
    According to the protocol, the sensitivity of the test was about 61% for IgM antibodies between days 7 and 14 of infection and 82% for IgG antibodies between days 11 and 15.
    IgG
    suggested: None
    Software and Algorithms
    SentencesResources
    Statistical analyses: We analyzed the obtained data using SPSS Ver.
    SPSS
    suggested: (SPSS, RRID:SCR_002865)

    Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).

    Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.

    Results from TrialIdentifier: No clinical trial numbers were referenced.

    Results from Barzooka: We found bar graphs of continuous data. We recommend replacing bar graphs with more informative graphics, as many different datasets can lead to the same bar graph. The actual data may suggest different conclusions from the summary statistics. For more information, please see Weissgerber et al (2015).

    Results from JetFighter: We did not find any issues relating to colormaps.

    Results from rtransparent:
    • Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
    • Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
    • No protocol registration statement was detected.

    About SciScore

    SciScore is an automated tool that is designed to assist expert reviewers by finding and presenting formulaic information scattered throughout a paper in a standard, easy to digest format. SciScore checks for the presence and correctness of RRIDs (research resource identifiers), and for rigor criteria such as sex and investigator blinding. For details on the theoretical underpinning of rigor criteria and the tools shown here, including references cited, please follow this link.

  3. Version published to 10.1101/2021.01.18.20248911v1 on medRxiv